Nomura Holdings Inc. cut its stake in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 80.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 82,525 shares of the medical instruments supplier’s stock after selling 330,764 shares during the quarter. Nomura Holdings Inc.’s holdings in DENTSPLY SIRONA were worth $3,612,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in the stock. Andra AP fonden grew its stake in DENTSPLY SIRONA by 156.8% during the second quarter. Andra AP fonden now owns 99,900 shares of the medical instruments supplier’s stock worth $4,373,000 after buying an additional 61,000 shares in the last quarter. Global X Management Co LLC grew its stake in DENTSPLY SIRONA by 30.0% during the second quarter. Global X Management Co LLC now owns 13,460 shares of the medical instruments supplier’s stock worth $589,000 after buying an additional 3,110 shares in the last quarter. MAI Capital Management grew its stake in DENTSPLY SIRONA by 27.2% during the second quarter. MAI Capital Management now owns 6,159 shares of the medical instruments supplier’s stock worth $270,000 after buying an additional 1,316 shares in the last quarter. Qube Research & Technologies Ltd acquired a new stake in DENTSPLY SIRONA during the second quarter worth about $134,000. Finally, HRT Financial LLC acquired a new stake in DENTSPLY SIRONA during the second quarter worth about $207,000. Institutional investors and hedge funds own 97.62% of the company’s stock.
NASDAQ XRAY traded up $0.19 during trading hours on Friday, reaching $35.87. The company’s stock had a trading volume of 2,241,844 shares, compared to its average volume of 2,663,035. The firm has a market cap of $8.39 billion, a PE ratio of 13.48, a price-to-earnings-growth ratio of 2.18 and a beta of 1.21. DENTSPLY SIRONA Inc has a 52 week low of $35.30 and a 52 week high of $68.98. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.69 and a quick ratio of 1.10.
DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Tuesday, August 7th. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.59 by $0.01. The business had revenue of $1.04 billion during the quarter, compared to analyst estimates of $1.03 billion. DENTSPLY SIRONA had a negative net margin of 39.62% and a positive return on equity of 9.12%. During the same quarter last year, the business earned $0.65 EPS. As a group, research analysts anticipate that DENTSPLY SIRONA Inc will post 2.08 earnings per share for the current fiscal year.
XRAY has been the topic of a number of research analyst reports. BidaskClub downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Thursday, September 27th. ValuEngine downgraded shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research note on Tuesday, September 4th. HC Wainwright set a $40.00 price target on shares of DENTSPLY SIRONA and gave the company a “hold” rating in a research note on Friday, August 31st. TheStreet downgraded shares of DENTSPLY SIRONA from a “c-” rating to a “d+” rating in a research note on Tuesday, August 14th. Finally, Barrington Research downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, August 9th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $52.18.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Read More: Why is insider trading harmful?
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.